Amgen Inc. reported its unaudited Q1 2026 earnings results on April 30, 2026, detailing key non-GAAP financial measures such as earnings per share and operating income. They emphasize that the non-GAAP figures, along with Free Cash Flow, provide better insights into the company's financial performance.